Founded in 2007
Financial data: €717M Market Cap (on 13/02/2017)
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life.
Tuborg Boulevard 12
Labiotech UG, All Rights Reserved -
Send this to friend